Wave Life Sciences Ltd. (WVE) Positive RestorAATion-2 Clinical Data Update Conference Transcript

Core Viewpoint - Wave Life Sciences announced a positive update from the ongoing RestorAATion-2 trial of WVE-006 for alpha-1 antitrypsin deficiency [2]. Group 1: Company Updates - The press release regarding the trial update was issued and is available in the Investor Relations section of the company's website [2]. - A slide presentation accompanying the conference call will be accessible on the website following the prepared remarks [2]. Group 2: Conference Call Details - The conference call is being recorded, and participants are reminded of this at the beginning of the call [1]. - Forward-looking statements will be discussed during the call, which are subject to various risks and uncertainties [3].